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        Upon antigen encounter, activated B cells of-
ten replace their heavy chain constant domain 
(C    ) with one of a set of downstream C  H   ex-
ons (C    , C    , or C    ) in a process known as 
class switch recombination (CSR). This intra-
chromosomal recombination event occurs be-
tween highly repetitive switch (S) sequences 
located upstream of each C  H   gene, with the 
exception of C    . CSR is targeted to specifi  c S 
regions by 5     I promoters that mediate germ-
line or sterile S-C  H   transcription (  1  ), and by 5     
and 3     heavy chain enhancers that promote S-S 
synapses (  2  ). These mechanisms cooperate to 
render S domains accessible to activation-in-
duced cytidine deaminase (AID) (  3, 4  ), a B cell  –
  specifi  c enzyme encoded by the   Aicda   gene that 
deaminates cytidine residues to uracils on both 
strands of S region DNA, resulting in U:G mis-
matches (  5  ). 
  Uracils are recognized and removed by uracil 
DNA glycosylase and mismatch repair enzymes 
(  6, 7  ), leading ultimately to the formation of 
DNA double-strand breaks (  6, 8, 9  ). These 
DNA lesions are processed by the nonhomol-
ogous end-joining proteins and other repair 
mechanisms that ensure effi   cient recombina-
tion (  10  ). If unrepaired, however, AID-medi-
ated DNA breaks can become substrates for 
chromosomal translocations that often juxta-
pose protooncogenes to the Ig loci. Canonical 
  Igh-cMyc   translocations, for instance, are the 
hallmark of both Burkitt  ’  s lymphomas in hu-
mans (T(8;14)) and plasmacytomas in mice 
(T(12;15)) (  11  ). 
  The role of AID in the etiology of   Igh-cMyc   
chromosomal translocations was implicated by 
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  Immunoglobulin (Ig) isotype switching is a recombination event that changes the constant 
domain of antibody genes and is catalyzed by activation-induced cytidine deaminase (AID). 
Upon recruitment to Ig genes, AID deaminates cytidines at switch (S) recombination sites, 
leading to the formation of DNA breaks. In addition to their role in isotype switching, AID-
induced lesions promote Igh-cMyc chromosomal translocations and tumor development. 
However, cMyc translocations are also present in lymphocytes from healthy humans and 
mice, and thus, it remains unclear whether AID directly contributes to the dynamics of B cell 
transformation. Using a plasmacytoma mouse model, we show that AID  +/      mice have reduced 
AID expression levels and display haploinsuffi  ciency both in the context of isotype switching 
and plasmacytomagenesis. At the Ig loci, AID  +/      lymphocytes show impaired intra- and inter-
switch recombination, and a substantial decrease in the frequency of S mutations and 
chromosomal breaks. In AID  +/      mice, these defects correlate with a marked decrease in the 
accumulation of B cell clones carrying   Igh-cMyc   translocations during tumor latency. These 
results thus provide a causality link between the extent of AID enzymatic activity, the num-
ber of emerging   Igh-cMyc    –  translocated cells, and the incidence of B cell transformation. 1950 AID CONTRIBUTES TO THE KINETICS OF B CELL TUMOR INCIDENCE   | Takizawa et al. 
decrease in     3 and     2a recombination between AID  +/+   and 
AID  +/      lymphocytes (P = 0.01 and P   <   0.0005 for     3 and 
    2, respectively;   n   = 5;   Fig. 2 B  ). CSR levels have been 
shown to be closely associated with cell division (  19, 20  ). We 
examined cell proliferation in AID  +/      and wild-type cul-
tures by CFSE labeling, and IgG1 switching was simultane-
ously determined by fl  ow cytometry. We found no obvious 
diff  erences in cell division between the two groups of B cells 
(  Fig. 2 C  , histograms). However,     1 switching in AID  +/      
lymphocytes lagged AID  +/+   by approximately two cell cycles 
(  Fig. 2 C  , graph), thus confi  rming that CSR levels are com-
promised in AID  +/      cells. 
  Lymphocytes activated for CSR undergo frequent AID-
dependent S deletions, predominantly at S     (  21, 22  ). To mea-
sure the incidence of intra-S     deletions, we generated IgM  +   
hybridoma clones from AID  +/+   and AID  +/      B cells stimu-
lated for 96 h in the presence of LPS and IL-4. Southern 
blotting showed a threefold reduction in intra-S     deletions 
in B cells carrying a single copy of   Aicda  , as only 9 out of 79 
AID  +/      clones (11%) displayed structural alterations in S    , 
whereas S deletions were present in 43 out of 110 AID  +/+   
clones analyzed (39%; P   <   0.0005;   Fig. 2 D  ). 
  Reduced inter- and intra-switch recombination in AID  +/      
cells could conceivably result from monoallelic expression of 
  Aicda  . Under this scenario, up to 50% of AID  +/      B cells would 
transcribe the neomycin-deleted allele, leading to a complete 
absence of AID expression and activity in 50% of cultured 
cells. To directly evaluate this idea, we monitored AID gene 
transcription by single-cell RT-PCR (  23  ). By this assay, only 
the untargeted   Aicda   allele is amplifi  ed using PCR primers 
specifi  c for AID exons 2 and 3, which are deleted by neomy-
cin insertion in the targeted allele (  3  ). We detected AID in 
185 out of 192 single AID  +/      B cells assayed (  Fig. 2 E  ), a 
  result that clearly demonstrates   Aicda   transcription to be bial-
lelic. We conclude that CSR defects in AID  +/      cultures re-
sult from a reduction in overall AID expression levels. 
  AID deamination leads to nucleotide substitutions at S 
domains (  24, 25  ), primarily as a result of DNA replication 
over uracils and error-prone repair activity (  6  ). To measure S 
mutation frequency, we cloned and sequenced the 5     end of 
S     from AID  +/      and wild-type lymphocytes stimulated with 
LPS and IL-4 for 96 h. Sequencing analysis showed a striking 
reduction in S     mutations in heterozygous cells (P   <   0.0005; 
  Fig. 2 F  ). The calculated mutation frequency in AID  +/      cells 
was in fact not signifi  cantly higher than the PCR error rate 
determined using AID      /      controls (P = 0.2;   Fig. 2 F  ). Col-
lectively, our data reveal that the frequency of S mutation 
and recombination in stimulated B cells is determined, at least 
in part, by AID gene dosage. 
  Reduced AID activity in AID  +/      mice 
during the immune response 
  We next examined AID activity during the humoral im-
mune response. AID  +/      and control BALB/c littermates were 
immunized in the front footpads by subcutaneous injection 
of 50   μ  g of chicken      globulin (CGG) in the presence of 
genetic experiments using AID      /      mice carrying IL-6 or Bcl-
xL transgenes (  12, 13  ). In both cases, deletion of AID resulted 
in the absence of canonical   cMyc   translocations. In H2AX      /      
B cells, AID was also required for CSR-mediated transloca-
tions (  14  ). In addition, several lines of evidence indicate that 
AID somatic hypermutation (SHM) activity may also promote 
tumor development by targeting non-Ig genes (  15  –  17  ). Using 
a plasmacytoma mouse model, we now demonstrate that the 
extent of AID activity infl  uences the incidence of B cell tumor 
development by directly determining the number of lympho-
cytes undergoing   Igh-cMyc   chromosomal translocations during 
tumor latency. 
    RESULTS AND DISCUSSION   
  Delayed plasma cell tumor development 
in AID heterozygous mice 
  Pristane injection of BALB/c mice expressing Bcl-2 or Bcl-
xL transgenes leads to the rapid induction of plasmacytomas 
carrying canonical   Igh-cMyc   translocations (  13, 18  ). In the 
  absence of AID, BALB/c-Bcl-xL mice display a reduced 
  incidence of plasmacytomas carrying translocations that are 
nonreciprocal and do not involve S regions (  13  ). To investi-
gate whether AID gene dosage contributes to tumor suscep-
tibility, we induced plasmacytomas in groups of BALB/c-Bcl-xL 
mice carrying one (AID  +/     ) or two copies of AID (AID  +/+  ). 
After pristane injection, the presence of plasma cell tumors in 
peritoneal oil granulomas was diagnosed by the appearance of 
tumor cells in the ascites. We found that AID  +/      mice devel-
oped tumors phenotypically indistinguishable from AID  +/+   as 
judged by histological features, the expression of mature 
plasma cell markers, or tumor recovery in transplantation as-
says (  Fig. 1 A   and not depicted).   However, there was a clear 
diff  erence in tumor incidence between the two groups of 
mice: the median tumor latency in AID  +/      animals (  n   = 96) 
was 102 d, whereas that of AID  +/+   mice (  n   = 41) was 82 d 
(P = 0.01;   Fig. 1 B  , left). In the absence of Bcl-xL, plasma-
cytomagenesis was, as expected, markedly delayed in both 
groups of mice. Still, AID heterozygous mice showed de-
creased tumor incidence relative to AID wild-type counterparts 
(  Fig. 1 B  , right). These results thus reveal a straight correla-
tion between AID gene dosage and the incidence of plasma 
cell tumor development. 
  Reduced CSR in stimulated AID  +/      B cells 
  The results described in the previous paragraph imply that 
AID activity is compromised in AID  +/      mice. To confi  rm 
this, we stimulated AID  +/      and AID  +/+   splenic B cells with 
LPS and IL-4, which induce AID transcription and CSR 
primarily to IgG1. Real-time PCR and Western blot anal-
yses showed lower AID mRNA and protein in activated 
AID  +/      lymphocytes compared with controls (  Fig. 2 A  ).   
This reduction in AID expression levels was correlated with 
impaired switching, as indicated by a 40  –  50% decrease in 
surface IgG1 expression in heterozygous cells relative to wild-
type (P   <   0.0005;   Fig. 2 B  ). B cell activation with LPS and 
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affi   nity maturation was aff  ected as a function of AID ex-
pression, AID  +/      and control mice were immunized intra-
peritoneally with hapten (4-hydroxy-3-nitrophenyl)acetyl 
(NP) conjugated to CGG (NP  25  -CGG) adsorbed to alum. 
The affi   nity of serum antibodies for NP was then moni-
tored 7 and 28 d after immunization by ELISA. In this assay, 
low affi   nity antibodies were captured using a high density 
NP-substituted BSA (NP  30  -BSA), whereas high affi   nity an-
tibodies were specifi  cally monitored with NP  7  -BSA. Low 
affi   nity IgG1 serum levels were not diff  erent between the 
two strains of mice (P = 0.8;   Fig. 3 C  , left). Nonetheless, 
we found a statistically signifi   cant reduction of high af-
fi  nity anti-NP antibodies in AID  +/      mice compared with 
wild-type counterparts (P = 0.006;   Fig. 3 C  , right). Thus, 
it seems likely that under conditions of limited AID activity, 
fewer AID  +/      B cell clones develop high affi   nity antibodies 
during the immune response. Based both on the CSR and 
SHM data, we conclude that the extent of AID enzymatic 
activity during the immune response is moderately aff  ected 
in AID  +/      mice. 
complete adjuvant. CSR levels were then monitored in ger-
minal centers (GCs) from axillary and brachial lymph nodes 
7 d after immunization. In agreement with the B cell culture 
results, we found fewer IgG1 B220  +  CD95  high   GC cells in 
AID  +/      mice relative to controls (P = 0.04;   Fig. 3 A  ).   Nota-
bly, the disparity in CSR levels between the two strains of 
mice was not as striking as that seen in ex vivo cultures. This 
might be explained by the combined facts that switched cells 
accumulate over time as a function of the cell cycle (  Fig. 2 C  ), 
and that B cell recruitment to and proliferation in GCs is ex-
tensive and asynchronized (  26  ). 
  To evaluate whether reduced AID expression levels af-
fected V gene hypermutation, we next cloned and sequenced 
the 5     end of the JH-E     intron (downstream of rearranged 
V  H  DJ  H4   genes) from sorted B220  +  CD95  high   GC cells. This 
analysis showed a comparable hypermutation frequency be-
tween the two groups of mice (P = 0.5). Notably, AID  +/      GCs 
harbored fewer clones carrying multiple mutations (  Fig. 3 B  ), 
suggesting a reduction in the accumulation of point muta-
tions in heterozygous cells. To directly evaluate whether 
    Figure 1.         Happloinsuffi  ciency in plasma cell tumor development in AID  +/      mice.   (A) Photomicrographs of plasma cell tumors arising in BALB/c-
Bcl-xL AID  +/+   and BALB/c-Bcl-xL AID  +/      mice show no signifi  cant variations in plasma cell morphology. Bar, 20   μ  m. (B, left) Incidence of plasma cell tu-
mors in the presence of Bcl-xL as determined by the histological appearance of foci, with each containing 50 or more atypical plasma cells (red squares, 
plasma cell tumors in 36 out of 41 AID  +/+   mice injected with pristane; black circles, plasma cell tumors in 58 out of 96 AID  +/      mice). (right) Plasmacytoma 
development in AID  +/+   ( n   = 16) and AID  +/      ( n   = 39) mice in the absence of Bcl-xL.     1952 AID CONTRIBUTES TO THE KINETICS OF B CELL TUMOR INCIDENCE   | Takizawa et al. 
    Figure 2.         Reduced AID activity in AID  +/      B cells.   (A) AID mRNA (graph, AID  +/+   and  AID +/    ;   n   = 5) and protein (AID  +/+ ,  AID +/     , and AID     /   ),  as 
measured by real-time PCR and Western blotting. Error bars represent the mean   ±   SD. (B, left) IgG1 switching (pseudocolor plot) profi  les in wild-type 
and AID  +/      B cells activated ex vivo, as determined by fl  ow cytometry. (right) Mean switching to IgG1, IgG3, and IgG2a. Values represent the mean   ±   
SD (  n   = 5). Antibodies were B220-PercP-Cy5.5 and IgG1-PE. Dead cells were gated out using DAPI. (C) Flow cytometric measurement of cell prolifera-
tion and IgG1 switching on CFSE-labeled B cells activated for 96 h with LPS + IL-4. The graph represents percentages of     1 switching at each cell 
division (  n   = 2). Error bars represent the mean   ±   SD. (D) The percentage of intra-switch deletions as determined by Southern blotting on hybridomas 
generated from AID  +/+   and  AID +/      lymphocytes activated for 96 h in the presence of LPS + IL-4. Intact S     domains result in a 6.9-kb band, whereas 
smaller bands (stars) represent intra-switch deletions. (E) Analysis of AID gene expression by single-cell RT-PCR (137 bp) from sorted LPS + IL-4  –
  activated B cells. (F) S     mutation frequency in AID  +/+ ,  AID +/     , and AID     /     activated B cells. Pie chart segments are proportional to the number of 
sequences carrying an equal number of mutations (indicated on the periphery). The total number of sequences is portrayed in the middle of each 
chart, and mutation frequency (calculated as the total mutations per total base pairs sequenced) and p-values are shown below the charts.     JEM VOL. 205, September 1, 2008  1953
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PCR was evaluated by Southern blotting using both   Igh  - and 
  cMyc  -specifi   c probes, and unique T(12;15)-positive clones 
were distinguished by their size (from 1  –  4 kb;   Fig. 4 A  ) and 
sequencing analysis ( Fig. 4 B ; and Table S1, available at http://
www.jem.org/cgi/content/full/jem.20081007/DC1). At 
day 25, an analysis of 57 PCR samples from AID  +/+   mice 
revealed nine distinct translocations (16%, or 1 T(12;15)/10  5   
cells;   Fig. 4 A  ). In contrast, only 2 out of 67 AID  +/      samples 
(3%, or 0.2 T(12;15)/10  5   cells) showed bona fi  de   Igh-cMyc   
translocations (P = 0.01;   Fig. 4 A   and Table S1). Similarly, 
22 out of 69 (30%) AID  +/+   samples showed translocations at 
day 35 after pristane treatment, whereas we detected only 
7 translocations in 72 (10%) AID  +/      samples assayed (2 vs. 
0.6 T(12;15)/10  5   cells, respectively; P = 0.001;   Fig. 4 A  ). In 
both groups of mice, the majority of the translocations were 
mapped to S     (    70%; Table S1), a feature that suggestively 
refl  ects the prevalence of IgA CSR in gut-associated lym-
phoid tissues (  23  ). Thus, compared with wild-type controls, 
AID  +/      mice display a substantial reduction in the number of 
translocation-bearing cells emerging upon tumor induction. 
  Diminished chromosome 12 breaks and   Igh-cMyc   
translocation  –  bearing cells in AID  +/      mice 
  Plasmacytomagenesis in pristane-treated mice is a multistep 
process initiated by the deregulation of   cMyc   upon transloca-
tion to the   Igh   loci. Fully malignant monoclonal tumors are 
thought to arise from a polyclonal pool of premalignant B 
cells bearing   cMyc   translocations (  27  ). We reasoned that de-
layed tumor development in AID  +/      mice might result from 
a reduction in the number of clones carrying   cMyc   translo-
cations. To investigate this, Bcl-xL transgenic AID  +/+   and 
AID  +/      mice were injected with pristane, and the presence 
of translocation-bearing cells before the onset of malignancy 
(approximately day 45;   Fig. 1 B  ) was determined by long-
distance PCR using nested primers specifi  c for S    , S    2a, S    , 
and   cMyc   intron 1 (  Fig. 4 A  , diagram).   At days 25 and 35 
after pristane treatment, canonical translocations were ampli-
fi  ed from DNA samples representing 5   ×   10  5   mononuclear 
cells isolated from Peyer  ’  s patches, mesenteric lymph nodes, 
or oil granuloma. DNA from three (day 35) or fi  ve (day 25) 
AID  +/+   or AID  +/      mice was analyzed. The specifi  city of the 
    Figure 3.         Reduced AID activity in AID  +/      mice during the immune response.   (A) Measurement of IgG1 levels in GCs from AID  +/+   and  AID +/      mice. 
Values represent the mean   ±   SD (  n   = 5). (B) Somatic hypermutation as determined by sequencing the JH4 intron from AID  +/+ ,  AID +/     , and AID     /     GC  cells. 
(C) ELISA analysis of serum from fi  ve AID  +/+   and  AID +/      mice immunized with NP-CGG. IgG1 antibodies displaying low affi  nity for NP were captured in this assay 
using NP  30  -BSA, whereas high affi  nity antibodies were monitored with NP  7  -BSA, as described in Results and discussion. Horizontal bars represent the mean.     1954 AID CONTRIBUTES TO THE KINETICS OF B CELL TUMOR INCIDENCE   | Takizawa et al. 
where a large number of unrepaired CSR lesions progress 
into chromosome breaks ( 14, 28, 29 ). These lesions, detected 
in metaphase spreads by fl  uorescence in situ hybridization 
(FISH) using VH- and C    -specifi  c probes, are good indica-
tors of the relative frequency of S DNA breaks occurring in 
  S recombination and   Igh-cMyc   translocations originate 
from DNA double-strand breaks targeting S domains in acti-
vated B cells (  14, 28  ). To evaluate whether the frequency of 
S DNA breaks was aff  ected in AID heterozygous mice, we 
bred the AID-deleted allele onto the H2AX      /      background, 
    Figure 4.         Paucity of translocation-bearing clones and CSR-induced DNA breaks in AID  +/      mice.   (A)   Igh-cMyc   chromosomal translocations in 
BALB/c-Bcl-xL AID  +/+   and BALB/c-Bcl-xL AID  +/      mice (three mice per time point) were amplifi  ed by PCR 25 or 35 d after pristane injection using nested 
primers (arrows) specifi  c for   cMyc   intron 1 and   Igh   C  ,  C   2b, and C     constant domains. PCR products were analyzed by Southern blotting using   cMyc -  and 
  Igh -specifi  c probes. (B) PCR products appearing multiple times were sequenced and counted once if they represented a single clone. (C)   Igh   FISH in meta-
phase spreads from AID  +/+ H2AX    /     and  AID +/    H2AX    /     B cells activated for CSR. (left) The loss of the red VH signal with an intact green C     signal  (micro-
graph) denotes a chromosome 12 break. (right) Total number of breaks observed for each strain (metaphases analyzed are indicated on top of each bar).     JEM VOL. 205, September 1, 2008  1955
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how S DNA breaks promote physiological recombination or 
pathological translocations in the B cell compartment. 
  MATERIALS AND METHODS 
  Tumor induction.     SV40-E  μ  -Bcl-xL and AID      /      (a gift from T. Honjo, 
Kyoto University, Kyoto, Japan) mice were backcrossed for 11 generations 
onto BALB/c mice in a conventional facility. Bcl-xL-AID  +/+   and Bcl-xL-
AID  +/      mice were given 0.5 ml of pristane oil intraperitoneally at 8 wk of age, 
followed by a second injection of pristane 60 d later. BALB/c-Bcl-xL AID  +/+   
and AID  +/      mice were intraperitoneally inoculated with 0.4 or 0.5 ml pristane 
(Aldrich Chemicals) at 2 mo of age. Using Wright-Giemsa  –  stained cytofuge 
preparations of ascites, plasma cell tumors were diagnosed by the presence of 
10 or more tumor cells per fi  eld. All animal experiments were performed ac-
cording to the NIH guidelines for laboratory animals and were approved by 
the Scientifi  c Committee of the NIAMS and NCI Animal Facilities. 
  B cell culture.     To induce S recombination ex vivo, B lymphocytes were 
isolated from spleens by immunomagnetic depletion using CD43 MACS 
beads (Miltenyi Biotec). Purifi  ed cells were then activated in B cell media 
(RPMI 1640, 10% FCS, 1  ×   antibiotic-antimycotic, 1% glutamine, 1  ×   nones-
sential amino acids, 1% sodium pyruvate, 14.2 M 2-  	  -mercaptoethanol, and 
10 mM Hepes) for 72 or 96 h in the presence of 25   μ  g/ml LPS (  Escherichia coli   
0111:B4; Sigma-Aldrich) and 5 ng/ml IL-4 (Invitrogen) to induce switching 
to IgG1, 2.5 ng/ml     -    -dextran (Fina Biosolutions) for IgG3 CSR, or 2 ng/
ml IFN-     (PeproTech) for IgG2a switching. Cell proliferation was monitored 
by CFSE staining according to the manufacturer  ’  s instructions (Invitrogen). 
  Flow cytometry.     Unless otherwise stated, the following antibodies were 
obtained from BD Biosciences: B220-PercP-Cy5.5, Fab    2-IgM-Cy5 (Jack-
son ImmunoResearch Laboratories), IgG1-PE, IgG3-biotin, streptavidin-
PE, and IgG2a-FITC. Apoptotic cells were gated out using TO-PRO-3 
(Invitrogen) or DAPI (Sigma-Aldrich). Flow cytometers used were the 
FACSCalibur (BD Biosciences) and the Cyan (Dako), and a MoFlo instru-
ment (Dako) was used for cell sorting. Flow cytometry data were analyzed 
with FlowJo software (Tree Star, Inc.). 
  qRT-PCR.     RNA was extracted with RNAqueous-Micro (Ambion) and 
treated with DNaseI. cDNA was synthesized, and the level of endogenous AID 
transcripts was monitored by real-time PCR with the following primers: Primer-
Bank-mAID5     (5    -gccaccttcgcaacaagtct-3    ) and PrimerBank-mAID3     (5    -ccg-
ggcacagtcatagcac-3    ). cDNA was normalized based on Ku80 mRNA with the 
following primers: QRT-mKu80-5     (5    -CTTCCTGGACGCCCTGA-
TTG-3    ) and QRT-mKu80-3     (5    -GCTGCGGAGGTCAGTGAAC-3    ). 
  Western blotting.     To detect AID protein, cultured B cells in the presence 
of LPS and IL-4 were lysed with NP-40 lysis buff  er (10 mM Tris-HCl [pH 
8], 150 mM NaCl, 0.5% NP-40, 5 mM EDTA, 1 mM DTT, and protease 
inhibitor cocktail). 50   μ  g per well of lysates was separated using NuPAGE 
4  –  12% Bis-Tris gels (Invitrogen). Gels were transferred to polyvinylidene 
fl  uoride membranes (Invitrogen) and analyzed by immunoblotting AID an-
tisera (a gift from J. Stavnezer, University of Massachusetts, Worcester, MA) 
and anti  –    	  -actin antibody (Millipore). For secondary antibodies, goat anti  –
  mouse IgG (Millipore) and goat anti  –  rabbit IgG conjugated with horserad-
ish peroxidase (HRP; Abcam) were used. Blots were visualized using the 
ECL-PLUS kit (GE Healthcare). 
  S     mutations.     Mutations at S     were determined by amplifying genomic 
DNA from LPS + IL-4  –  activated (96 h) B cells with primers S    (B) (5    -gta-
aggagggacccaggctaag-3    ) and S    (D) (5    -cagtccagtgtaggcagtaga-3    ) at 95  °  C 
for 30 s, 60  °  C for 30 s, and 72  °  C for 30 s (product = 650 bp). The fi  nal 
product was ligated into ZeroBlunt vector (Invitrogen), and positives clones 
were sequenced with M13 primers. 
  FISH analysis.     At 72 h, cultured B cells were arrested at mitosis with 100 
ng/ml colcemid (Roche), swollen in prewarmed 0.075 M KCl for 15 min at 
G1 (  14, 28, 29  ). Analysis of metaphase spreads from AID  +/+ 
H2AX      /      and AID  +/     H2AX      /      B cells stimulated with LPS 
and IL-4 for 96 h showed a direct correlation between the 
frequency of CSR breaks and AID gene dosage. Although 
17.5% of all AID  +/+  H2AX      /      metaphases displayed split 
VH/C     signals, only 9% of all AID  +/     H2AX      /      metaphases 
showed evidence of chromosome 12 breaks (  Fig. 4 C  ). We 
conclude that S domain DNA breaks are diminished in AID 
heterozygous B cells. 
  We have shown that the absence of a single copy of   Aicda   
aff  ects the rate of intrachromosomal recombination and in-
terchromosomal translocations involving the   Igh   loci. This 
haploinsuffi   ciency for AID is likely explained by the marked 
reduction in the frequency of formation and availability of 
S-DNA lesions in AID  +/      cells. The strong inference is that 
AID protein content falls below a critical threshold in lym-
phocytes carrying a single copy of   Aicda  . Such a threshold 
might be imposed by mechanisms controlling nuclear AID 
(  30, 31  ), which represents a minor fraction of total AID pro-
tein in activated B cells (  32  ). Alternatively, error-free repair 
pathways, which have been shown to inhibit both CSR 
and SHM (  17, 33  ), may compromise AID activity to a 
greater extent under conditions of limited AID transcrip-
tion. Regardless of the mechanism at work, our fi  ndings dem-
onstrate that AID expression levels directly determine the 
extent of AID-dependent DNA remodeling events, includ-
ing chromosomal translocations. Thus, AID expression levels 
appear to determine the incidence of plasmacytomagenesis 
by specifying the number of   cMyc   translocation  –  bearing clones 
emerging during tumor induction. Overt transformation of 
such clones may subsequently rely on a mistargeted SHM, 
which as we have shown is also dependent on the amount 
of AID. 
  Our previous work revealed that noncanonical T(12;15) 
translocations can occur in the absence of AID (  13  ). On the 
other hand, canonical translocations targeting S region DNA 
and   cMyc   intron 1 absolutely require AID enzymatic activity 
(  12, 13  ). We now extend these results by showing that AID 
expression levels directly determine the rate of canonical 
translocations emerging during tumor induction in vivo. 
Ramiro et al. have similarly shown that   cMyc   translocations 
can be induced in an AID-dependent manner in vitro (  28  ). 
In that study, translocations were rarely present under physi-
ological AID levels in LPS- and IL-4  –  stimulated B cells, 
whereas AID overexpression dramatically increased their fre-
quency (  28  ). In like manner,   Igh-cMyc   translocations are pro-
duced to a disproportionately high degree in stimulated B 
lymphocytes defi  cient for microRNA 155 (  34  ), which nor-
mally suppresses the steady state of   Aicda   mRNA and AID 
protein content (  34, 35  ). We fi  nd it noteworthy that although 
the frequency of off  -target translocations is highly sensitive to 
AID expression levels, in vivo on-target SHM and CSR are 
only mildly aff  ected by AID overexpression (  34  ) or underex-
pression (this report). It seems likely that AID enzymatic ac-
tivity is diff  erentially constrained at on and off   targets. The 
unraveling of such regulatory mechanisms might help clarify 1956 AID CONTRIBUTES TO THE KINETICS OF B CELL TUMOR INCIDENCE   | Takizawa et al. 
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37  °  C and fi  xed by methanol/acetic acid treatment, and dropped in micro-
scope slides using a humidity chamber (Thermotron). Slides were denatured 
in 75  °  C 70% formamide for 7 min; hybridized with following probes over-
night at 37  °  C; washed, dehydrated, and stained with DAPI; and mounted 
with Vectashield (Vector Laboratories). BAC probes containing the IgH C     
and Vh regions were labeled by digoxigenin and a biotin nick translation kit 
(Roche), and were detected by antidigoxigenin FITC antibody (Roche), and 
Alexa Fluor 568  –  conjugated streptavidin (Invitrogen). FISH images were 
captured using an epifl  uorescence microscope (DMRB Leitz; Leica) and a 
charge-coupled device camera (model C4742-95; Hamamatsu Photonics). 
  Hybridoma analysis.     Analysis of CD43        MACS-isolated B cells were 
stimulated with LPS + IL-4 for 96 h and fused to the SP2/0Ag-14 myeloma 
cell line. IgM-secreting clones, as determined by ELISA, were expanded in 
culture for further analysis. Genomic DNA was prepared and Southern blot 
analysis was performed using standard techniques. 
  Detection of   Igh-cMyc   translocations and plasma cell tumors.     Tissue 
samples were harvested 25 or 35 d after pristane injection. DNA samples 
from three (day 35) and fi  ve (day 25) mice were prepared as followed: Pey-
er  ’  s patches (three samples per mouse), mesenteric lymph nodes (two samples 
per mouse), and oil granuloma (two samples per mouse). Tissues were col-
lected in separate tubes and DNA was isolated individually. The sensitivity 
of the translocation PCR was measured using serial dilution of positive con-
trol cells with wild-type mouse liver cells and calculated as   >  6.25 T(12;15) 
positive cells/10  5   negative cells. PCR products were separated on 1% aga-
rose gels and denatured for 15 min in the presence of 0.4 M NaOH before 
being transferred to nylon membranes. The Southern blot probe was ampli-
fi  ed and labeled by the ECL Direct Labeling and Detection System (GE 
Healthcare). Probe primer sequences were as follows: c-myc forward, 5    -gct-
agcgcagtgaggagaag-3    ; c-myc reverse, 5    -gacgccactgcaccagaga-3    ; C     for-
ward, 5    -agccagtgtctcagaggga-3    ; C     reverse, 5    -cttaaggcaggcagggcta-3    ; 
C    2  	   forward, 5    -aagtcagaccgtcacctgca-3    ; C    2  	   reverse, 5    -cagaggatcat-
gtccttgagtg-3    ; C     forward, 5    -tgctggctgatcttcagtctc-3    ; and C     reverse, 
5    -ttgaacatgacctgcaggtagtc-3    . 
  ELISA.     Five AID  +/+   and AID  +/      mice were immunized intraperitoneally 
with 100   μ  g NP  25  -CGG precipitated in Alum (Thermo Fisher Scientifi  c). Sera 
were collected before and at 7 or 28 d after immunization. Serum anti-NP lev-
els were measured by standard ELISA. Plates were coated with 5   μ  g/ml NP  30  -
BSA or NP  7  -BSA in PBS. Serum samples were diluted, and bound antibody 
was detected using HRP-conjugated anti  –  mouse IgG (Bethyl) followed by 
3,3    ,5,5    -tetramethylbenzidine treatment. 
  Online supplemental material.     Table S1 shows the translocation PCR/
Southern blot results from AID  +/+  , AID  +/     , and AID      /      mice carry-
ing Bcl-xL. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20081007/DC1. 
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